New radiation approach targets liver tumors without surgery

NCT ID NCT03408665

Ongoing Disease control Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a precise type of radiation called SBRT for people with liver cancer or tumors that have spread to the liver. It includes 280 participants with various liver tumor types. The goal is to see how well SBRT controls tumor growth and what side effects occur.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SBRT (stereotactic body radiation therapy)
What this could lead to: If successful, this could provide a non-invasive treatment option to control liver tumors and delay progression.
What could go wrong: This is a phase II study, so results are preliminary. The treatment may not improve survival or could cause side effects like liver damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholangiocarcinoma hepatocellular carcinoma liver cancer Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER CANCER LIVER METASTASES

Contacts and locations

Locations

Centre Léonard de Vinci

Dechy, France
Centre Oscar Lambret

Lille, Nord, 59020, France
Centre Paul Strauss

Strasbourg, France
Institut Gustave Roussy

Villejuif, 94800, France
Institut Régional du Cancer de Montpellier

Montpellier, France
Institut de Cancérologie Paris Nord

Sarcelles, 95200, France
Institut de Cancérologie de Lorraine

Vandœuvre-lès-Nancy, 54519, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.